MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells
返回论文页
Short communication|更新时间:2023-05-16
|
MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells
MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells
Genes & Diseases2023年10卷第2期
作者机构:
1. College of Life Science and Bioengineering, Beijing Jiaotong University,Beijing,China,100044
2. National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University,Guangxi,Nanning,China,530021
MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells[J]. Genes & Diseases, 2023,10(2).
Shi Liu, Yanmin Wu, Haiqiang Chen, et al. MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells[J]. Genes & Diseases, 2023,10(2).
MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.04.021.
Shi Liu, Yanmin Wu, Haiqiang Chen, et al. MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.04.021.
MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells